73498-24-5 Usage
Uses
Used in Medicinal Chemistry:
5-CHLOROBENZO[D]ISOXAZOL-3-YLAMINE is used as a key intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with unique mechanisms of action.
Used in Agrochemicals:
In the agrochemical industry, 5-CHLOROBENZO[D]ISOXAZOL-3-YLAMINE is utilized as a building block for the creation of novel agrochemicals, potentially enhancing crop protection and yield.
Used in Drug Discovery and Development:
5-CHLOROBENZO[D]ISOXAZOL-3-YLAMINE is employed as a research target in drug discovery and development due to its unique structure and biological activities, which may lead to the identification of new therapeutic agents.
Used in Synthesis of Biologically Active Molecules:
As a valuable building block, 5-CHLOROBENZO[D]ISOXAZOL-3-YLAMINE is used in the synthesis of a variety of biologically active molecules, contributing to the advancement of pharmaceutical and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 73498-24-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,4,9 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73498-24:
(7*7)+(6*3)+(5*4)+(4*9)+(3*8)+(2*2)+(1*4)=155
155 % 10 = 5
So 73498-24-5 is a valid CAS Registry Number.
73498-24-5Relevant academic research and scientific papers
AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF A7-NICOTINIC ACETYLCHOLINE RECEPTORS
-
Paragraph 00197, (2017/01/31)
The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of ot7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.
